Tethered Education® Method: Connecting Clinicians to the Latest Science to Improve Clinical Decisions That Matter Most to Patients With HER2+ Breast Cancer

Gain expert insights into the optimal use of HER2-targeted approaches in the treatment of your patients with HER-positive metastatic breast cancer with this decision support tool and associated patient resources.
Neelima Denduluri, MD, FASCO
Sara Hurvitz, MD, FACP
Ian E. Krop, MD, PhD
Heather McArthur, MD, MPH
Ruth O'Regan, MD
Sara Tolaney, MD, MPH
person default
Tiffany A. Traina, MD

Interactive Decision Support Tool

Use this Interactive Decision Support Tool to compare your choice of therapy for patients with HER2-positive metastatic breast cancer with those of 7 breast cancer experts.

Neelima Denduluri, MD, FASCO Sara Hurvitz, MD, FACP Ian E. Krop, MD, PhD Heather McArthur, MD, MPH Ruth O'Regan, MD Sara Tolaney, MD, MPH person default Tiffany A. Traina, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits Released: August 20, 2020 Expired: August 19, 2021
Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Produced in collaboration with
Supported by an educational grant from
Daiichi Sankyo, Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue